Vanessa M. Lucey, PhD, MBA, is participating in the panel discussion "IO Session I: Combination Failures & Futures: Much Ado About What?" on May 7, 2019 at 3:15 p.m.<\/p>\n
Jill O'Donnell-Tormey, PhD, is participating in the panel discussion "Biotech Deal-Making in the Face of IO Frenzy or Fatigue: Same Old or Different New?" on May 8, 2019 at 12:30 p.m. <\/p>\n
Since 1989, Cancer Progress invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this an impactful conference.<\/p>\n
The 30th Annual Meeting of Cancer Progress on May 7-8, 2019 will provide a learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference.<\/p>\n
The 30th Annual Meeting will be held at Convene at 32 Old Slip, New York, NY 10005. <\/p>\n